Lymphatica Medtech SA, a leading medical device Swiss startup pioneering advancements in lymphedema treatment, announces the receipt of Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its revolutionary product, LymphoDrain. This breakthrough designation represents a significant milestone in the journey toward transforming the treatment landscape for chronic lymphedema.
